("progressive supranuclear palsy"[tiab:~0]) AND ("english and humans"[Filter]) AND ( ("practice guideline"[Filter]) OR (practice*[titl] AND (guideline[titl] OR parameter[titl] OR resource[titl] OR bulletin[titl] OR best[titl])) OR (genetic*[titl] AND - Search Results

Save citations to file

Email citations

Subject: ("progressive supranuclear palsy"[tiab:~0]) AND ( - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

("progressive supranuclear palsy"[tiab:~0]) AND ("english and humans"[Filter]) AND ( ("practice guideline"[Filter]) OR (practice*[titl] AND (guideline[titl] OR parameter[titl] OR resource[titl] OR bulletin[titl] OR best[titl])) OR (genetic*[titl] AND (evaluation[titl] OR counseling[titl] OR screening[titl] OR test*[titl])) OR (clinical[titl] AND ((expert[titl] AND consensus[titl]) OR utility[titl] OR guideline*[titl])) OR (management[titl] AND (clinical[titl] OR diagnos*[titl] OR recommendation[titl] OR pain[titl] OR surveillance[titl] OR emergency[titl] OR guideline*[titl] OR therap*)) OR (treatment[titl] AND ((evaluation[titl] AND diagnosis[titl]) OR (assessment[titl] AND prevention[titl]) OR therap*)) OR (Diagnos*[titl] AND (prenatal[titl] OR treatment[titl] OR follow-up[titl] OR statement[titl] OR criteria[titl] OR newborn[titl] OR differential[titl] OR neonatal[titl] OR neonate[titl])) OR (guideline*[titl] AND (pharmacogenetic*[titl] OR recommendation[titl] OR therap*[titl] OR evidence-based[titl] OR consensus[titl] OR (technical[titl] AND standard*[titl]) OR (molecular[titl] AND testing[titl]))) OR (risk[titl] AND assessment[titl]) OR (recommendation*[titl] AND (statement[titl] OR Evidence-based[titl] OR Consensus[titl])) OR (care AND ((Patient[titl] AND standard*[titl]) OR primary[titl] OR psychosocial[titl])) OR (Health[titl] AND supervision[titl]) OR (statement[titl] AND (policy[titl] OR position[titl] OR Consensus[titl])) OR (pharmacogenetics[titl] AND (Dosing[titl] OR therap*[titl] OR genotype*[titl] OR drug*[titl])) OR (Chemotherapy[titl] AND decision*[titl]) OR (screening[titl] AND (newborn[titl] OR neonat*[titl] OR detection[titl] OR diagnos*[titl])) OR (criteria[titl] OR genotype*[titl]) ) NOT ("Case reports"[Publication type] OR "clinical study"[Publication Type] OR "randomized controlled trial"[Publication Type])

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
1973	1
1981	1
1982	1
1983	1
1984	1
1992	1
1993	1
1994	4
1995	4
1996	6
1997	1
1999	3
2000	3
2001	5
2002	1
2003	5
2004	2
2005	3
2006	3
2007	5
2008	6
2009	5
2010	6
2011	3
2012	12
2013	10
2014	6
2015	8
2016	6
2017	16
2018	13
2019	14
2020	18
2021	15
2022	10
2023	6
2024	5

186 results

Page of 19

Results by year

Page 1

Progressive supranuclear palsy: diagnosis and management.

Rowe JB, Holland N, Rittman T. Rowe JB, et al. Pract Neurol. 2021 Oct;21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2. Pract Neurol. 2021. PMID: 34215700 Free PMC article. Review.

Treating patients with progressive supranuclear palsy (PSP) is both effective and rewarding. ...

Progressive supranuclear palsy: Advances in diagnosis and management.

Coughlin DG, Litvan I. Coughlin DG, et al. Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25. Parkinsonism Relat Disord. 2020. PMID: 32487421 Free PMC article. Review.

Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no current cure or disease modulating therapies that can only be definitively confirmed at autopsy. ...Current ongoing clinical trials target the abnormal aggregation of t …

Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no current cure or disease modulating …

The Differential Diagnosis and Treatment of Atypical Parkinsonism.

Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU. Levin J, et al. Dtsch Arztebl Int. 2016 Feb 5;113(5):61-9. doi: 10.3238/arztebl.2016.0061. Dtsch Arztebl Int. 2016. PMID: 26900156 Free PMC article. Review.

BACKGROUND: Aside from idiopathic Parkinson syndrome (Parkinson's disease), there are a number of other, so-called atypical parkinsonian syndromes: dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corti …

BACKGROUND: Aside from idiopathic Parkinson syndrome (Parkinson's disease), there are a number of other, so-called atypical parkinsonian syn …

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I; Movement Disorder Society-endorsed PSP Study Group. Höglinger GU, et al. Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3. Mov Disord. 2017. PMID: 28467028 Free PMC article.

Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Boxer AL, et al. Lancet Neurol. 2017 Jul;16(7):552-563. doi: 10.1016/S1474-4422(17)30157-6. Epub 2017 Jun 13. Lancet Neurol. 2017. PMID: 28653647 Free PMC article. Review.

Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes that are associated with a characteristic 4-repeat tau neuropathology. ...Because PSP is a …

Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recogni …

Criteria for the diagnosis of corticobasal degeneration.

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tröster AI, Vidailhet M, Weiner WJ. Armstrong MJ, et al. Neurology. 2013 Jan 29;80(5):496-503. doi: 10.1212/WNL.0b013e31827f0fd1. Neurology. 2013. PMID: 23359374 Free PMC article.

Combined with consensus, 4 CBD phenotypes emerged: corticobasal syndrome (CBS), frontal behavioral-spatial syndrome (FBS), nonfluent/agrammatic variant of primary progressive aphasia (naPPA), and progressive supranuclear palsy syndrome (PSPS). ...

Combined with consensus, 4 CBD phenotypes emerged: corticobasal syndrome (CBS), frontal behavioral-spatial syndrome (FBS), nonfluent/agramma …

(18)F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment.

Meyer PT, Frings L, Rücker G, Hellwig S. Meyer PT, et al. J Nucl Med. 2017 Dec;58(12):1888-1898. doi: 10.2967/jnumed.116.186403. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912150 Free article. Review.

Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic importance. In addition, with the development of invasive therapies and novel disease-specific therapies, strategies for patient enrichment in trial populations are of …

Accurate differential diagnosis of parkinsonism is of paramount therapeutic and prognostic importance. In addition, with the developm …

Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.

Minoshima S, Mosci K, Cross D, Thientunyakit T. Minoshima S, et al. Semin Nucl Med. 2021 May;51(3):230-240. doi: 10.1053/j.semnuclmed.2021.01.002. Epub 2021 Feb 2. Semin Nucl Med. 2021. PMID: 33546814 Review.

PET images with [F-18]FDG demonstrate distinct patterns of decreased uptake for Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD) as well as its multiple subtypes such as behavioral variant FTD, primary progressive aphasia (PPA), …

PET images with [F-18]FDG demonstrate distinct patterns of decreased uptake for Alzheimer's disease (AD), Dementia with Lewy bodies (DLB), a …

Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.

Veilleux Carpentier A, McFarland NR. Veilleux Carpentier A, et al. Curr Opin Neurol. 2023 Aug 1;36(4):309-316. doi: 10.1097/WCO.0000000000001163. Epub 2023 May 31. Curr Opin Neurol. 2023. PMID: 37381926 Review.

PURPOSE OF REVIEW: Since the original description of progressive supranuclear palsy (PSP) by Steele, Richardson and Olszewski, the clinical spectrum of PSP has expanded and now includes multiple phenotypic variants linked by a common disease. ...SUMMARY: Alth …

PURPOSE OF REVIEW: Since the original description of progressive supranuclear palsy (PSP) by Steele, Richardson and Ols …

Diagnosis and Differential Diagnosis of Parkinson Disease.

Caproni S, Colosimo C. Caproni S, et al. Clin Geriatr Med. 2020 Feb;36(1):13-24. doi: 10.1016/j.cger.2019.09.014. Epub 2019 Sep 17. Clin Geriatr Med. 2020. PMID: 31733693 Review.

186 results

Page of 19

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

186 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year